Blood Molecules Tied to Brain Aging Risk
Researchers link 16 blood molecules to dementia risk during the menopause transition, according to a study published in Nature Medicine.
Updated on Nov. 9, 2026 in Alzheimer’s

Live Poll
Would you want a blood test that screens your midlife dementia risk?
A study published in Nature Medicine identified 16 blood molecules whose levels rise with brain aging and dementia risk across menopause. Protein changes tracked menopause stage more closely than chronological age.
Why it matters
Women spend roughly one third of their lives after menopause, a period when cognitive and dementia risk may shift. Identifying molecular markers could help clinicians recognize risk earlier.
The study drew on proteomic measurements in the Jacobs Lab's Healthy Aging Study, with associations replicated in more than 2,800 UK Biobank women and four cohorts totaling nearly 12,000 older women. Whether the protein signature predicts dementia reliably in individuals, rather than only in groups, remains unknown.
The players
Madeline Wood Alexander
Lead author of the study at Sunnybrook Research Institute in Canada, who has worked on women's brain health and aging.
Rowan Saloner
Researcher at UC San Francisco who co-led the study alongside Kaitlin Casaletto.
Kaitlin Casaletto
Researcher at UC San Francisco who co-led the study on menopause and brain aging.
The details
Researchers examined thousands of proteins in women at different menopause stages and found that the molecular changes aligned more closely with menopause stage than with exact age. Women with higher levels of the risk proteins showed poorer cognitive outcomes across the cohorts studied.
Timeline
Over the following 16 years, women in the largest cohort were followed for Alzheimer's dementia risk.
Health Landscape
The work fits within the Longitudinal Menopause Project, which will follow women across the menopause transition to test how brain health changes unfold. The findings point toward menopause as a window for dementia risk assessment rather than age alone.
The research aims toward a blood test that could flag dementia risk earlier, but no such test is available yet. Women going through menopause should not change care based on these molecular findings, which remain experimental.
The takeaway
Menopause may be a meaningful stage for tracking brain health, since the study links molecular changes more closely to menopause stage than to age. Ongoing longitudinal research will be needed before these markers guide individual care.
Further reading
For more on the disease at the center of this research, see Alzheimer’s.
Source note: This article includes information reported by Edhat Santa Barbara.
Live Poll
Would you want a blood test that screens your midlife dementia risk?







